Showing results (281-290 of 349) with videos related to

Sort By:
Pageof 35
Journal of the National Cancer Institute|October 17, 1998
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomasJ G Cairncross, K Ueki, M C Zlatescu, et al.
Gene Therapy|September 25, 1998
Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vectorU Herrlinger, C M Kramm, K S Aboody-Guterman, et al.
Cancer Research|November 23, 2006
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entitiesElizabeth A Maher, Cameron Brennan, Patrick Y Wen, et al.
Cancer Cell|June 28, 2002
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axisRobert M Bachoo, Elizabeth A Maher, Keith L Ligon, et al.
Brain Pathology (Zurich, Switzerland)|April 18, 1998
Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSLJ M Cobbers, M Wolter, J Reifenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatmentDaniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.
Acta Neuropathologica|January 29, 2011
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytomaGenevieve Schindler, David Capper, Jochen Meyer, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumorsSusan M Chang, Wendy Seiferheld, Walter Curran, et al.
Cell Reports|May 28, 2013
An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastomaEsther Rheinbay, Mario L Suvà, Shawn M Gillespie, et al.
Neuro-Oncology|November 30, 2018
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse gliomaTejus A Bale, Justin T Jordan, Otto Rapalino, et al.
Pageof 35